/Investor DB

Aarin Capital — 2017 Investments

1 investments dated 2017 · listed companies and verified rows first · show all

Sayre Therapeuticssayretherapeutics.cominSep 2017 · $8M

Sayre Therapeutics is a pharmaceutical company operating across India, South Asia, and Southeast Asia that distributes differentiated global drugs and treatments for rare and orphan diseases to emerging markets.

BiotechDigital HealthMedical DevicesBangalore, IN

Shukrit

Co-investorsAccel

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.